Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

512 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New approaches in psychiatric drug development.
van der Doef TF, Zaragoza Domingo S, Jacobs GE, Drevets WC, Marston HM, Nathan PJ, Tome MB, Tamminga CA, van Gerven JMA, Kas MJH. van der Doef TF, et al. Among authors: tamminga ca. Eur Neuropsychopharmacol. 2018 Sep;28(9):983-993. doi: 10.1016/j.euroneuro.2018.06.006. Epub 2018 Jul 25. Eur Neuropsychopharmacol. 2018. PMID: 30056086 Review.
Biological fingerprints for psychosis.
Tamminga CA, Clementz BA. Tamminga CA, et al. Neuropsychopharmacology. 2020 Jan;45(1):235-237. doi: 10.1038/s41386-019-0505-6. Neuropsychopharmacology. 2020. PMID: 31558770 Free PMC article. No abstract available.
Biotyping in psychosis: using multiple computational approaches with one data set.
Tamminga CA, Clementz BA, Pearlson G, Keshavan M, Gershon ES, Ivleva EI, McDowell J, Meda SA, Keedy S, Calhoun VD, Lizano P, Bishop JR, Hudgens-Haney M, Alliey-Rodriguez N, Asif H, Gibbons R. Tamminga CA, et al. Neuropsychopharmacology. 2021 Jan;46(1):143-155. doi: 10.1038/s41386-020-00849-8. Epub 2020 Sep 26. Neuropsychopharmacology. 2021. PMID: 32979849 Free PMC article. Review.
Psychosis is emerging as a learning and memory disorder.
Tamminga CA. Tamminga CA. Neuropsychopharmacology. 2013 Jan;38(1):247. doi: 10.1038/npp.2012.187. Neuropsychopharmacology. 2013. PMID: 23147488 Free PMC article. Review. No abstract available.
Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders.
Eum S, Hill SK, Alliey-Rodriguez N, Stevenson JM, Rubin LH, Lee AM, Mills LJ, Reilly JL, Lencer R, Keedy SK, Ivleva E, Keefe RSE, Pearlson GD, Clementz BA, Tamminga CA, Keshavan MS, Gershon ES, Sweeney JA, Bishop JR. Eum S, et al. Among authors: tamminga ca. Neuropsychopharmacology. 2021 Sep;46(10):1802-1810. doi: 10.1038/s41386-021-01057-8. Epub 2021 Jun 18. Neuropsychopharmacology. 2021. PMID: 34145405 Free PMC article.
Developing novel treatments for mood disorders: accelerating discovery.
Tamminga CA, Nemeroff CB, Blakely RD, Brady L, Carter CS, Davis KL, Dingledine R, Gorman JM, Grigoriadis DE, Henderson DC, B Innis RB, Killen J, Laughren TP, McDonald WM, M Murphy GM Jr, Paul SM, Rudorfer MV, Sausville E, Schatzberg AF, Scolnick EM, Suppes T. Tamminga CA, et al. Biol Psychiatry. 2002 Sep 15;52(6):589-609. doi: 10.1016/s0006-3223(02)01470-1. Biol Psychiatry. 2002. PMID: 12361670 Review.
The GABAβ receptor as a target for antidepressant drug action.
Ghose S, Winter MK, McCarson KE, Tamminga CA, Enna SJ. Ghose S, et al. Among authors: tamminga ca. Br J Pharmacol. 2011 Jan;162(1):1-17. doi: 10.1111/j.1476-5381.2010.01004.x. Br J Pharmacol. 2011. PMID: 20735410 Free PMC article. Review.
512 results